Ask any caregiver what keeps them going, and you will hear a common answer: love. Caregivers support people living with pancreatic cancer in every way imaginable — from lending a listening ear and ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...

The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called PNET or PanNET. “I am delighted that patients with pancreatic ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights about the latest news ...

While pancreatic cancer remains one of the toughest cancers to treat and is predicted to become the second-leading cause of cancer-related death in the U.S. before 2030, research and treatment ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...

A device already approved to treat several other types of cancer has shown positive results for a subset of patients with pancreatic cancer. In a Phase III clinical trial, a therapy known as Tumor ...

Tacos, tamales, tostadas; cuando la gente piensa en la comida mexicana, la primer palabra que viene a su mente suele ser "sabroso". Si bien esos platillos tradicionales mexicanos pueden tener un alto ...

On World Gratitude Day, we want to express our deepest thanks to you and the rest of the incredible PanCAN community. You raise funds, spread awareness, advocate for increased federal funding, and ...

PanCAN’s new Chief Scientific and Medical Officer, Anna Berkenblit, MD, MMSc, has nearly 20 years of experience bringing new therapies to patients with cancer. She’s served in leadership roles in ...